NOVOCURE LTD - NOTE 11/0

CUSIP: 67011XAB9

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Debt / NOTE 11/0
Market price (% of par)
91.15%
Total 13F principal
$580,224,000
Principal change
+$17,942,997
Total reported market value
$530,625,512
Number of holders
23
Value change
+$19,444,332
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 67011XAB9?
CUSIP 67011XAB9 identifies 67011XAB9 - NOVOCURE LTD - NOTE 11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q1 2024

As of 31 Mar 2024, NOVOCURE LTD - NOTE 11/0 was held by 23 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $580,224,000 in principal (par value) of the bond. The largest 10 bondholders included BRAIDWELL LP, TENOR CAPITAL MANAGEMENT Co., L.P., Opti Capital Management, LP, Voya Investment Management LLC, DeepCurrents Investment Group LLC, Linden Advisors LP, STEELHEAD PARTNERS LLC, Balyasny Asset Management L.P., Verition Fund Management LLC, and STATE STREET CORP. This page lists 23 institutional bondholders reporting positions for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.